Evaluating a Cognitive Remediation Intervention for Women During the Menopausal Transition: A Pilot Study
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Menopause
- Sponsor
- St. Joseph's Healthcare Hamilton
- Enrollment
- 27
- Locations
- 1
- Primary Endpoint
- change in self-reported cognitive difficulties
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
The goal in this study is to evaluate the effectiveness of a cognitive remediation program that was designed specifically to address the concerns related to cognitive difficulties that are often reported among women in the menopausal transition. This cognitive remediation program has been created to provide our clients with an opportunity to learn more about the relation between menopause and cognitive function, to learn new strategies to enhance thinking skills (e.g., memory, attention) and to hear about lifestyle changes that are known to have a beneficial effect on mental functioning.
Investigators
Elena Ballantyne
Principal Investigator
St. Joseph's Healthcare Hamilton
Eligibility Criteria
Inclusion Criteria
- •Currently in menopausal transition
- •Subjective cognitive complaints
- •Presence of vasomotor menopausal symptoms (i.e., hot flashes)
Exclusion Criteria
- •Individuals with acute and severe depression
- •Suicidal ideation
- •Severe PTSD
- •Psychosis
- •Severe alcohol/substance use issues
Outcomes
Primary Outcomes
change in self-reported cognitive difficulties
Time Frame: At the beginning of the first session and at the conclusion of the 5th session to assess change over time. That means measures will be administered 5 weeks later.
beliefs about general memory abilities, confidence in decision-making abilities, confidence in one's ability to focus or concentrate, and high standards regarding one's cognitive performance using the Memory and Cognitive Confidence Scale (MACCS)
Secondary Outcomes
- Subjective distress(At the beginning of the first session and at the conclusion of the 5th session to assess change over time. That means measures will be administered 5 weeks later.)
- Vasomotor symptoms(At the beginning of the first session and at the conclusion of the 5th session to assess for change over time. That means measures will be administered 5 weeks later.)
- Beliefs(At the beginning of the first session and at the conclusion of the 5th session to assess for change over time. That means measures will be administered 5 weeks later.)